d-alpha tocopherol has been researched along with lacidipine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Locher, R; Lupo, E; Vetter, W; Weisser, B | 1 |
| Bianchi, A; Capizzi, RL; Capuzzi, DM; D'Armiento, FP; de Nigris, F; Donzelli, R; Godfraind, T; Gonnella, JS; Mancini, M; Napoli, C; Palinski, W; Palumbo, G; Salomone, S | 1 |
| Campagnola, M; Cominacini, L; Cristofori, P; Crivellente, F; Faustinelli, I; Garbin, U; Pasini, AF; Rigoni, A; Tosetti, M; Turton, J | 1 |
3 other study(ies) available for d-alpha tocopherol and lacidipine
| Article | Year |
|---|---|
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
Topics: Adult; Amlodipine; Antioxidants; Calcium Channel Blockers; Copper; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; Isradipine; Lipoproteins, LDL; Oxidation-Reduction; Reference Values; Thiobarbituric Acid Reactive Substances; Verapamil; Vitamin E | 1994 |
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Apolipoproteins B; Arteries; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Epitopes; Genetic Predisposition to Disease; Immunohistochemistry; Lipoproteins, LDL; Male; Oxidation-Reduction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Vitamin E | 1999 |
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.
Topics: Animals; Antioxidants; Apolipoproteins E; Arteriosclerosis; Calcium Channel Blockers; Dihydropyridines; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Mice; Mice, Knockout; Random Allocation; Vitamin E | 2004 |